Effects of temporarily suspending low-dose methotrexate treatment for 2 weeks after SARS-CoV-2 vaccine booster on vaccine response in immunosuppressed adults with inflammatory conditions: protocol for a multicentre randomised controlled trial and nested mechanistic substudy (Vaccine Response On/Off Methotrexate (VROOM) study)
出版年份 2022 全文链接
标题
Effects of temporarily suspending low-dose methotrexate treatment for 2 weeks after SARS-CoV-2 vaccine booster on vaccine response in immunosuppressed adults with inflammatory conditions: protocol for a multicentre randomised controlled trial and nested mechanistic substudy (Vaccine Response On/Off Methotrexate (VROOM) study)
作者
关键词
-
出版物
BMJ Open
Volume 12, Issue 5, Pages e062599
出版商
BMJ
发表日期
2022-05-03
DOI
10.1136/bmjopen-2022-062599
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants
- (2022) Catherine J. Reynolds et al. SCIENCE
- An Evidence-Based Guide to SARS-CoV-2 Vaccination of Patients on Immunotherapies in Dermatology
- (2021) Louise M. Gresham et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
- (2021) Jennifer M. Dan et al. SCIENCE
- Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection
- (2021) Catherine J. Reynolds et al. Science Immunology
- Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals
- (2021) Charlotte Manisty et al. LANCET
- Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine
- (2021) Maria Prendecki et al. LANCET
- BNT162b vaccines protect rhesus macaques from SARS-CoV-2
- (2021) Annette B. Vogel et al. NATURE
- SARS-CoV-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virus
- (2021) Mikail Dogan et al. Communications Biology
- Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab
- (2021) Nicholas A Kennedy et al. GUT
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose
- (2021) Catherine J. Reynolds et al. SCIENCE
- Effectiveness of inactivated influenza vaccine in autoimmune rheumatic diseases treated with disease-modifying anti-rheumatic drugs
- (2020) Georgina Nakafero et al. RHEUMATOLOGY
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
- (2020) Pedro M Folegatti et al. LANCET
- Factors associated with COVID-19-related death using OpenSAFELY
- (2020) Elizabeth J. Williamson et al. NATURE
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison
- (2020) Mark Ainsworth et al. LANCET INFECTIOUS DISEASES
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
- (2020) Edward E. Walsh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study
- (2020) Ash K Clift et al. BMJ-British Medical Journal
- T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
- (2020) Katie J. Ewer et al. NATURE MEDICINE
- Development and validation of a methotrexate adherence assay
- (2019) James Bluett et al. ANNALS OF THE RHEUMATIC DISEASES
- Impact of temporary methotrexate discontinuation for 2 weeks on immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial
- (2018) Jin Kyun Park et al. ANNALS OF THE RHEUMATIC DISEASES
- Methotrexate and BAFF interaction prevents immunization against TNF inhibitors
- (2018) Samuel Bitoun et al. ANNALS OF THE RHEUMATIC DISEASES
- Methotrexate preferentially affects Tc1 and Tc17 subset of CD8 T lymphocytes
- (2018) Amit Sandhu et al. CLINICAL RHEUMATOLOGY
- Interaction between B-cell activation factor and methotrexate impacts immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis
- (2018) Jin Kyun Park et al. ANNALS OF THE RHEUMATIC DISEASES
- Rheumatoid arthritis is getting less frequent—results of a nationwide population-based cohort study
- (2017) Abhishek Abhishek et al. RHEUMATOLOGY
- Incidence, prevalence and mortality of patients with psoriasis: a U.K. population-based cohort study
- (2016) D.A. Springate et al. BRITISH JOURNAL OF DERMATOLOGY
- Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range
- (2016) Dehui Luo et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range
- (2015) Xiang Wan et al. BMC Medical Research Methodology
- The incidence and prevalence of systemic lupus erythematosus in the UK, 1999–2012
- (2014) Frances Rees et al. ANNALS OF THE RHEUMATIC DISEASES
- Distinct Effects of Methotrexate and Etanercept on the B Cell Compartment in Patients With Juvenile Idiopathic Arthritis
- (2014) Stephanie Glaesener et al. Arthritis & Rheumatology
- Global prevalence of ankylosing spondylitis
- (2013) L. E. Dean et al. RHEUMATOLOGY
- Effect of Methotrexate, Anti-Tumor Necrosis Factor α, and Rituximab on the Immune Response to Influenza and Pneumococcal Vaccines in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
- (2013) Charlotte Hua et al. ARTHRITIS CARE & RESEARCH
- Regional and temporal variation in the treatment of rheumatoid arthritis across the UK: a descriptive register-based cohort study
- (2012) Christopher John Edwards et al. BMJ Open
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started